文献速递乳腺癌

2004至2013年非老年乳腺癌黑人白人女性生存差异归因分析

Factors That Contributed to Black-White Disparities in Survival Among Nonelderly Women With Breast Cancer Between 2004 and 2013.
PubMed 文献 · J Clin Oncol · 2017-10-16

该研究基于美国国家癌症数据库2004至2013年确诊的563,497例18至64岁I至III期乳腺癌黑人及白人女性,采用倾向评分优化匹配与多变量风险比,序贯评估人口学、合并症、保险、肿瘤特征和治疗对总生存差异的贡献。激素受体阳性者(占78.5%)人口学匹配后黑人较白人死亡HR为2.05(95%CI 1.94至2.17),依次匹配合并症、保险、肿瘤特征和治疗后降至1.93、1.54、1.30、1.25;上述因素合计解释76.3%的超额死亡风险,其中保险占37.0%、肿瘤特征占23.2%、合并症占11.3%、治疗占4.8%。

要点

  • 激素受体阳性者人口学匹配后黑人较白人死亡HR 2.05(95%CI 1.94至2.17)。
  • 依次匹配合并症、保险、肿瘤特征、治疗后HR降至1.93、1.54、1.30、1.25。
  • 保险解释超额死亡风险的37.0%,肿瘤特征解释23.2%。

核心结论

  • 匹配保险可解释非老年早期乳腺癌黑人较白人女性超额死亡风险的三分之一,匹配肿瘤特征可解释约五分之一;聚焦公平可及性可能大幅缩小总生存的种族差异。

研究设计与样本

  • 基于美国国家癌症数据库2004至2013年确诊的18至64岁I至III期乳腺癌女性,共563,497例黑人及白人患者,按激素受体状态分层,采用序贯倾向评分优化匹配及多变量风险比分析。

主要发现

  • 激素受体阳性者占全部患者的78.5%;人口学匹配模型黑人较白人死亡HR 2.05(95%CI 1.94至2.17)。
  • 依次匹配合并症、保险、肿瘤特征、治疗后HR分别为1.93(95%CI 1.83至2.04)、1.54(95%CI 1.47至1.62)、1.30(95%CI 1.24至1.36)、1.25(95%CI 1.19至1.31)。
  • 上述因素合计解释黑人患者总超额死亡风险的76.3%,其中保险37.0%、肿瘤特征23.2%、合并症11.3%、治疗4.8%。
  • 激素受体阴性者结果总体相似,但HR明显更小。

临床怎么用

  • 研究提示保险与肿瘤特征是非老年早期乳腺癌黑人白人总生存差异的主要可解释因素,原文提出聚焦照护可及性公平化可能大幅缩小该差异。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Purpose To estimate the contribution of differences in demographics, comorbidity, insurance, tumor characteristics, and treatment to the overall mortality disparity between nonelderly black and white women diagnosed with early-stage breast cancer. Patients and Methods Excess relative risk of all-cause death in black versus white women diagnosed with stage I to III breast cancer, expressed as a percentage and stratified by hormone receptor status for each variable (demographics, comorbidity, insurance, tumor characteristics, and treatment) in sequentially, propensity-scored, optimally matched patients by using multivariable hazard ratios (HRs). Results We identified 563,497 white and black women 18 to 64 years of age diagnosed with stage I to III breast cancer from 2004 to 2013 in the National Cancer Data Base. Among women with hormone receptor-positive disease, who represented 78.5% of all patients, the HR for death in black versus white women in the demographics-matched model was 2.05 (95% CI, 1.94 to 2.17). The HR decreased to 1.93 (95% CI, 1.83 to 2.04), 1.54 (95% CI, 1.47 to 1.62), 1.30 (95% CI, 1.24 to 1.36), and 1.25 (95% CI, 1.19 to 1.31) when sequentially matched for comorbidity, insurance, tumor characteristics, and treatment, respectively. These factors combined accounted for 76.3% of the total excess risk of death in black patients; insurance accounted for 37.0% of the total excess, followed by tumor characteristics (23.2%), comorbidities (11.3%), and treatment (4.8%). Results generally were similar among women with hormone receptor-negative disease, although the HRs were substantially smaller. Conclusion Matching by insurance explained one third of the excess risk of death among nonelderly black versus white women diagnosed with early-stage breast cancer; matching by tumor characteristics explained approximately one fifth of the excess risk. Efforts to focus on equalization of access to care could substantially reduce ethnic/racial disparities in overall survival among nonelderly women diagnosed with breast cancer.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Jemal A, Robbins AS, Lin CC, et al. Factors That Contributed to Black-White Disparities in Survival Among Nonelderly Women With Breast Cancer Between 2004 and 2013. J Clin Oncol. 2017. PMID: 29035645. doi:10.1200/JCO.2017.73.7932

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。